ACIU
Price:
$2.88
Market Cap:
$232.51M
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases. The company is developing Crenezumab, a humanized, conformation-specific monoclonal antibody, which is in Phase II clinical prevention trial for the treatment of Alzheimer's disease (AD). It is also developing ACI-24, an anti-Abeta vaccine candidate that is ...[Read more]
Industry
Biotechnology
IPO Date
2016-09-23
Stock Exchange
NASDAQ
Ticker
ACIU
According to AC Immune S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -3.24. This represents a change of -270.12% compared to the average of 1.90 of the last 4 quarters.
The mean historical PE Ratio of AC Immune S.A. over the last ten years is -10.06. The current -3.24 PE Ratio has changed 3.12% with respect to the historical average. Over the past ten years (40 quarters), ACIU's PE Ratio was at its highest in in the December 2017 quarter at 44.70. The PE Ratio was at its lowest in in the December 2016 quarter at -39.07.
Average
-10.06
Median
-5.05
Minimum
-93.25
Maximum
42.77
Discovering the peaks and valleys of AC Immune S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 194.87%
Maximum Annual PE Ratio = 42.77
Minimum Annual Increase = -318.00%
Minimum Annual PE Ratio = -93.25
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -4.80 | -26.90% |
| 2023 | -6.56 | 194.87% |
| 2022 | -2.23 | -51.95% |
| 2021 | -4.63 | -12.58% |
| 2020 | -5.30 | -141.40% |
| 2019 | 12.80 | -213.46% |
| 2018 | -11.28 | -59.84% |
| 2017 | -28.10 | -69.87% |
| 2016 | -93.25 | -318.00% |
| 2015 | 42.77 | -46.69% |
The current PE Ratio of AC Immune S.A. (ACIU) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.53
5-year avg
-4.70
10-year avg
-10.06
AC Immune S.A.’s PE Ratio is greater than Aldeyra Therapeutics, Inc. (-5.79), greater than Cellectis S.A. (-8.40), greater than Alto Neuroscience, Inc. (-5.58), less than Silence Therapeutics plc (-1.93), greater than Amarin Corporation plc (-79.20), greater than Contineum Therapeutics, Inc. Class A Common Stock (-5.20), less than Lyell Immunopharma, Inc. (-1.14), greater than Mereo BioPharma Group plc (-6.58), greater than Annexon, Inc. (-3.56), greater than Alpha Tau Medical Ltd. (-8.51),
| Company | PE Ratio | Market cap |
|---|---|---|
| -5.79 | $293.49M | |
| -8.40 | $484.47M | |
| -5.58 | $415.67M | |
| -1.93 | $336.78M | |
| -79.20 | $340.44M | |
| -5.20 | $320.40M | |
| -1.14 | $540.20M | |
| -6.58 | $325.72M | |
| -3.56 | $536.98M | |
| -8.51 | $346.14M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AC Immune S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AC Immune S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is AC Immune S.A.'s PE Ratio?
How is the PE Ratio calculated for AC Immune S.A. (ACIU)?
What is the highest PE Ratio for AC Immune S.A. (ACIU)?
What is the 3-year average PE Ratio for AC Immune S.A. (ACIU)?
What is the 5-year average PE Ratio for AC Immune S.A. (ACIU)?
How does the current PE Ratio for AC Immune S.A. (ACIU) compare to its historical average?